Oligonucleotide drugs have been utilized in the prevention and treatment of various diseases. To enhance their stability and facilitate transmembrane delivery, lipid nanoparticles(LNPs) are commonly employed as carriers. However, the poor stability of miRNA-LNPs results in stringent storage requirements, limiting their broad application. Therefore, this study investigated the effects of formulation and process parameters on miRNA-LNPs physical stability, using particle size and encapsulation efficiency as key indicators. The results indicated that various phospholipids contributed to the physical stability of LNPs, among which PEGylated phospholipids effectively preventing LNPs aggregation. The phase transition of water directly destroyed the LNPs structure, and the combination of cryoprotectant sucrose and PEGylated phospholipids could effectively resist the damage caused by water phase transition to the LNPs structure. By elucidating the mechanisms by which structural materials and water phase transitions affect miRNA-LNPs physical stability, this study introduced cryoprotectants as a novel strategy to improve the physical stability of oligonucleotide drug-loaded LNPs. These findings provide valuable insights for optimizing LNP-based formulations, thereby strengthening the clinical applicability of small nucleic acid therapeutics.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |